167 related articles for article (PubMed ID: 3146552)
1. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD
Infection; 1988; 16(6):365-70. PubMed ID: 3146552
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Maskell JP; Sefton AM; Williams JD
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
[TBL] [Abstract][Full Text] [Related]
3. In-vitro susceptibility of oral streptococci to pristinamycin.
Maskell JP; Williams JD
J Antimicrob Chemother; 1987 May; 19(5):585-90. PubMed ID: 3112093
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro activity of RP 59500.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():39-44. PubMed ID: 1399949
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
Pechère JC
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
[TBL] [Abstract][Full Text] [Related]
6. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Rospide MF; Biedenbach DJ; Jones RN
Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
[TBL] [Abstract][Full Text] [Related]
7. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
Fass RJ
Antimicrob Agents Chemother; 1991 Mar; 35(3):553-9. PubMed ID: 1903912
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of A-56268.
Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates.
Qadri SM; Ueno Y; Abu Mostafa FM; Halim M
Chemotherapy; 1997; 43(2):94-9. PubMed ID: 9084917
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.
Finch RG
Drugs; 1996; 51 Suppl 1():31-7. PubMed ID: 8724814
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of RU-66647, a new ketolide.
Jones RN; Biedenbach DJ
Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
[TBL] [Abstract][Full Text] [Related]
15. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Williams JD; Maskell JP; Whiley AC; Sefton AM
J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Dunkin KT; Jones S; Howard AJ
J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of pristinamycin on respiratory bacteria].
Leclercq R
Presse Med; 1999 Sep; 28 Suppl 1():6-9. PubMed ID: 10506876
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
Weber P; Dubois S; Boussougant Y
J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
Yu KW; Neu HC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1839-42. PubMed ID: 2126695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
